Skip to main content

BIOTECHS DEMAND DISCIPLINE, CLARITY, AND DEPTH

Oncology Expertise Rooted In Rigor, Insight, and Precision

HiRO Oncology

Oncology studies demand a level of discipline, clarity, and scientific depth that few CROs can consistently deliver. HiRO’s oncology teams bring together global experience, advanced biometrics, and deep therapeutic expertise to guide each study with calm, evidence-driven confidence.

Through our Linkage™ Approach, we connect people, systems, and data into a unified framework—helping sponsors navigate complexity, anticipate challenges, and move forward with decisions grounded in truth. From early-phase exploration to late-phase global programs, our work reflects the structure, consistency, and precision modern oncology development requires.

Oncology IRO
HiRO Oncology

Our experience spans complex oncology trials, including biomarker-driven studies, adaptive designs, and combination therapies. This isn’t just oncology experience—it’s the ability to bring clarity to programs where variability, speed, and scientific rigor must all coexist.

Oncology Indicators

HiRO supports a broad range of oncology programs across solid tumors, hematologic malignancies, and all-comers designs. Our teams are experienced in complex protocols, biomarker-driven studies, and multi-regional oncology trials requiring disciplined execution and regulatory alignment.

Solid Tumors

  • Lung Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Colorectal Cancer
  • Glioblastoma Cancer
  • Prostate Cancer

Hematologic Malignancies

  • Leukemia
  • Multiple Myeloma
  • Lymphomas

Advanced Oncology Programs

  • Immuno-oncology therapies
  • Targeted therapies and precision medicine
  • Combination and biomarker-driven studies
  • Rare and orphan oncology indications

Oncology Experience By The Numbers

Our oncology experience spans early-phase exploration through late-phase global development, supported by disciplined data practices and regionally aligned execution. These numbers reflect the consistency and scale sponsors rely on when programs grow in complexity.

37

Tumor Types, Including Rare & Orphan

430

Oncology Studies

7.8K

Global Oncology Sites

76K

Global Patients

How HiRO Restored Momentum in a
Phase I Oncology Program

See how HiRO stabilized and advanced an active Phase I oncology study following a CRO transition, applying disciplined biometrics, inspection-ready oversight, and steady investigator engagement. This case highlights HiRO’s ability to protect enrollment, maintain patient safety, and restore sponsor confidence in high-pressure oncology programs.

HiRO Oncology Study

Rescue and Transition of a Phase I Oncology Study

Download Study
15

Total oncology sites transitioned during active enrollment.

5

Additional oncology studies awarded following successful Phase II expansion.

DISCIPLINE MEETS ADAPTIVE EXECUTION

A Modern Approach
To Oncology

Oncology trials require a partner who can bring structure to complexity and clarity to every decision. With protocols becoming more intricate and timelines under pressure, sponsors need guidance that is both disciplined and adaptive. HiRO combines biometrics rigor, transparent communication, and thoughtful oversight to help teams move through each stage with confidence.

By integrating global operational strength with deep oncology expertise, we ensure every program benefits from unified standards and connected teams. Through our Linkage™ Approach, studies move forward with consistent communication, aligned expectations, and the collective insight of shared experience across regions.

Regulatory Confidence
From Strategy to IND

We don’t just manage timelines—we help oncology sponsors navigate the entire regulatory journey with confidence. From early development strategy and IND planning through submission and beyond, our teams bring deep expertise in global oncology requirements and evolving regulatory pathways.

Proactive Planning
Anticipating protocol complexity, biomarker strategy, and regulatory challenges before they impact timelines.

Integrated Approach
Aligning clinical, biometrics, and operational strategies to support faster, more confident execution.

Global Perspective
Supporting multi-regional oncology programs with consistent standards and regulatory alignment.

Collaborative Partnership
Working side-by-side with sponsors to ensure clarity, compliance, and confident decision-making at every stage.

Our goal is simple: help you move from concept to clinic with the discipline, precision, and confidence oncology development demands.

Book A Meeting Today With
Our Oncology Team

Schedule Today